finance.yahoo.comGT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference9 months ago
finance.yahoo.comGT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 202410 months ago
finance.yahoo.comGT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemiaabout 1 year ago
finance.yahoo.comGT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rulesabout 1 year ago
benzinga.comWhy Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionabout 1 year ago